Literature DB >> 16101164

Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy.

Hiroyuki Kato1, Minoru Fukuchi, Tatsuya Miyazaki, Masanobu Nakajima, Hitoshi Kimura, Ahmad Faried, Makoto Sohda, Yasuyuki Fukai, Norihiro Masuda, Ryokuhei Manda, Hitoshi Ojima, Katsuhiko Tsukada, Hiroyuki Kuwano.   

Abstract

BACKGROUND: Although patients with recurrent diseases have a very poor prognosis, appropriate pretreatment classification for management of recurrent esophageal cancers has yet to be identified. The patterns of recurrence following radial esophagectomy were retrospectively assessed, and evaluated for possible adaptation as a novel classification of recurrent esophageal cancer. PATIENTS AND METHODS: One hundred and sixty thoracic esophageal cancer patients (142 men; 18 women), who underwent radical esophagectomy without preoperative treatment, were studied.
RESULTS: Recurrence occurred in 59 (36.8%) patients. The relationship between recurrence and clinicopathological features revealed significant associations between recurrence and age at surgery (p<0.05), tumor (p<0.0001), lymph node (p<0.0001) and metastatic status (p<0.01), pathological stage (p<0.0001) and lymph node dissection (p<0.0001). Locoregional recurrence occurred in 13 (22%) patients, distant in 30 (51%) and mixed in 16 (27%). Mixed recurrence occurred the fastest and showed the poorest prognosis. A novel classification for recurrent esophageal cancer was proposed based on the clinical findings. Univariate analysis of the prognostic factors for post-recurrent survival revealed a significant association with distant organ recurrence (p<0.05).
CONCLUSION: Mixed recurrence had a poorer outcome than other recurrences. The proposed classification of clinical findings for recurrent esophageal cancer was shown to be useful; however, further studies with a larger number of recurrent esophageal cancers are required for stage grouping of the proposed classification.

Entities:  

Mesh:

Year:  2005        PMID: 16101164

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

1.  Patterns and time of recurrence after complete resection of esophageal cancer.

Authors:  Masahiko Sugiyama; Masaru Morita; Rintaro Yoshida; Koji Ando; Akinori Egashira; Ohga Takefumi; Hiroshi Saeki; Eiji Oki; Yoshihiro Kakeji; Yoshihisa Sakaguchi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-02-28       Impact factor: 2.549

2.  Pattern of postoperative recurrence and hepatic and/or pulmonary resection for liver and/or lung metastases from esophageal carcinoma.

Authors:  Hirofumi Ichida; Hiroshi Imamura; Jiro Yoshimoto; Hiroyuki Sugo; Yoshiaki Kajiyama; Masahiko Tsurumaru; Kenji Suzuki; Yoichi Ishizaki; Seiji Kawasaki
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

3.  Lymphadenectomy via a cervical approach for upper mediastinal lymph node recurrence of esophageal cancer: report of a case.

Authors:  Hiroyuki Tada; Atsushi Shiozaki; Hitoshi Fujiwara; Daisuke Ichikawa; Kazuma Okamoto; Shuhei Komatsu; Yasutoshi Murayama; Hisashi Ikoma; Yoshiaki Kuriu; Masayoshi Nakanishi; Toshiya Ochiai; Yukihito Kokuba; Teruhisa Sonoyama; Eigo Otsuji
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

4.  Case involving long-term survival after esophageal cancer with liver and lung metastases treated by multidisciplinary therapy: report of a case.

Authors:  Daisuke Iitaka; Atsushi Shiozaki; Hitoshi Fujiwara; Daisuke Ichikawa; Kazuma Okamoto; Shuhei Komatsu; Yasutoshi Murayama; Hisashi Ikoma; Yoshiaki Kuriu; Masayoshi Nakanishi; Toshiya Ochiai; Yukihito Kokuba; Teruhisa Sonoyama; Eigo Otsuji
Journal:  Surg Today       Date:  2012-07-01       Impact factor: 2.549

5.  Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.

Authors:  Kotaro Yamashita; Masayuki Watanabe; Shinji Mine; Takanori Kurogochi; Akihiko Okamura; Masaru Hayami; Yu Imamura
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

6.  Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus.

Authors:  Masayuki Watanabe; Shinji Mine; Kazuhiko Yamada; Hironobu Shigaki; Yoshifumi Baba; Naoya Yoshida; Kiyoshi Kajiyama; Noriko Yamamoto; Takeshi Sano; Hideo Baba
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-06-26

7.  [Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1].

Authors:  R Rossi; T Jaeger; C Börgermann; C Furtkamp; R Moos Stahl; H Rübben; F vom Dorp
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

8.  Follow-up after surgery for gastric cancer: how to do it.

Authors:  Daniela Zanotti; Gian Luca Baiocchi; Arianna Coniglio; Borzoueh Mohammadi; Silvia Ministrini; Muntzer Mughal; Guido A M Tiberio; Khaled Dawas
Journal:  Updates Surg       Date:  2018-03-26

9.  Treatment of Anastomotic Recurrence After Esophagectomy.

Authors:  Rebecca A Carr; Caitlin Harrington; Elvira Vos; Manjit S Bains; Matthew J Bott; James M Isbell; Bernard J Park; Smita Sihag; David R Jones; Daniela Molena
Journal:  Ann Thorac Surg       Date:  2021-09-10       Impact factor: 5.102

10.  Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.

Authors:  K Parry; E Visser; P S N van Rossum; N Haj Mohammad; J P Ruurda; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2015-09-03       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.